Jeffrey S Mathiesen - Net Worth and Insider Trading
Jeffrey S Mathiesen Net Worth
The estimated net worth of Jeffrey S Mathiesen is at least $127 dollars as of 2024-05-15. Jeffrey S Mathiesen is the CFO and Treasurer of Helius Medical Technologies Inc and owns about 79 shares of Helius Medical Technologies Inc (HSDT) stock worth over $123. Jeffrey S Mathiesen is also the CFO of NeuroBo Pharmaceuticals Inc and owns about 1 shares of NeuroBo Pharmaceuticals Inc (NRBO) stock worth over $4. Details can be seen in Jeffrey S Mathiesen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jeffrey S Mathiesen has not made any transactions after 2021-12-17 and currently still holds the listed stock(s).
Transaction Summary of Jeffrey S Mathiesen
Jeffrey S Mathiesen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey S Mathiesen owns 7 companies in total, including Panbela Therapeutics Inc (PBLA) , NeuroOne Medical Technologies Corp (NMTC) , and Helius Medical Technologies Inc (HSDT) among others .
Click here to see the complete history of Jeffrey S Mathiesen’s form 4 insider trades.
Insider Ownership Summary of Jeffrey S Mathiesen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PBLA | Panbela Therapeutics Inc | 2015-09-24 | director |
| NMTC | NeuroOne Medical Technologies Corp | 2017-08-04 | director |
| HSDT | Helius Medical Technologies Inc | 2022-09-13 | director & CFO and Treasurer |
 | | 2016-08-10 | Chief Financial Officer |
| | 2013-09-08 | Chief Financial Officer |
| | 2005-10-06 | Vice President and CFO |
| | 2022-03-31 | director |
Jeffrey S Mathiesen Latest Holdings Summary
Jeffrey S Mathiesen currently owns a total of 2 stocks. Among these stocks, Jeffrey S Mathiesen owns 79 shares of Helius Medical Technologies Inc (HSDT) as of December 17, 2021, with a value of $123 and a weighting of 96.77%. Jeffrey S Mathiesen also owns 1 shares of NeuroBo Pharmaceuticals Inc (NRBO) as of August 10, 2016, with a value of $4 and a weighting of 3.23%.
Latest Holdings of Jeffrey S Mathiesen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HSDT | Helius Medical Technologies Inc | 2021-12-17 | 79 | 1.56 | 123 |
| NRBO | NeuroBo Pharmaceuticals Inc | 2016-08-10 | 1 | 4.11 | 4 |
Holding Weightings of Jeffrey S Mathiesen
Jeffrey S Mathiesen Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey S Mathiesen has made a total of 1 transactions in Helius Medical Technologies Inc (HSDT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Helius Medical Technologies Inc is the acquisition of 60 shares on December 17, 2021, which cost Jeffrey S Mathiesen around $15,930.
According to the SEC Form 4 filings, Jeffrey S Mathiesen has made a total of 0 transactions in NeuroBo Pharmaceuticals Inc (NRBO) over the past 5 years. The most-recent trade in NeuroBo Pharmaceuticals Inc is the acquisition of 1 shares on August 10, 2016, which cost Jeffrey S Mathiesen around $40,000.
Insider Trading History of Jeffrey S Mathiesen
- 1
Jeffrey S Mathiesen Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey S Mathiesen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey S Mathiesen is -19.2%. GuruFocus also compares Jeffrey S Mathiesen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey S Mathiesen within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey S Mathiesen's insider trading performs compared to the benchmark.
Performance of Jeffrey S Mathiesen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 15.89 | | | | | |
| Relative Return to S&P 500(%) | 16.53 | | | | | |
Jeffrey S Mathiesen Ownership Network
Jeffrey S Mathiesen Owned Company Details
What does Panbela Therapeutics Inc do?
Who are the key executives at Panbela Therapeutics Inc?
Jeffrey S Mathiesen is the director of Panbela Therapeutics Inc. Other key executives at Panbela Therapeutics Inc include director & President and CEO Jennifer K. Simpson , V.P. of Finance & CFO Susan Horvath , and 10 percent owner Ryan Randall Gilbertson .
Panbela Therapeutics Inc (PBLA) Insider Trades Summary
Over the past 18 months, Jeffrey S Mathiesen made no insider transaction in Panbela Therapeutics Inc (PBLA). Other recent insider transactions involving Panbela Therapeutics Inc (PBLA) include a net sale of 72,874 shares made by Goldman Sachs Group Inc , a net purchase of 4,444 shares made by Susan Horvath , and a net purchase of 4,444 shares made by Jennifer K. Simpson .
In summary, during the past 3 months, insiders sold 0 shares of Panbela Therapeutics Inc (PBLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,644 shares of Panbela Therapeutics Inc (PBLA) were sold and 444 shares were bought by its insiders, resulting in a net sale of 3,199 shares.
Panbela Therapeutics Inc (PBLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Panbela Therapeutics Inc Insider Transactions
Jeffrey S Mathiesen Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey S Mathiesen. You might contact Jeffrey S Mathiesen via mailing address: 43334 Seven Mile Rd., Suite 1000, Northville Mi 48167.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
